NYSE •
Healthcare •
Drug Manufacturers - General •
Quote as of 09/18/2026 16:00
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization251,013 mln
Float1,550 mln
Earnings Date10/30/2026
EPS
6.60
Strong
P / E
25.16
Elevated
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.56
Likely reliable
1-Year Forecast
212
Strong upside
Relative Strength
87
/ 100
Strongly outperforming
Business Description
AstraZeneca is a global medicine company based in Cambridge, UK, that researches, develops, and sells prescription drugs across a wide range of health areas, including cancer, heart and kidney disease, respiratory conditions, rare diseases, and vaccines. The company markets an extensive portfolio of treatments to both primary care and specialist physicians through distribution networks and sales offices across Europe, the Americas, Asia, Africa, and Australasia. Originally formed from the merger of Zeneca and Astra AB, the company has built on over three decades of operation and continues to pursue partnerships ? such as those with Tempus, Pathos, and CSPC Pharmaceutical Group ? to advance next-generation therapies.
